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We have examined the ability of a commercial mixture of polychlorinated biphenyls (Aroclor 1254) to induce hepatic 
cytochrome P-4X?-linked enzyme activities in rat and pigeon liver five days after its intraperitoneal injection. The results 
provide evidence that, at the doses used, Aroclor 1254 induces cytochrome P-452-linked enzyme activities in rats, but 
not in pigeons. This inductive effect was previously regarded as being specific for hypolipidemic drugs and phthalate ster 
plasticisers. 
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1. INTRODUCTION 
Polychlorinated biphenyls (PCBs) are fat- 
soluble commercial products noted for their 
chemical stability, miscibility with organic 
solvents, non-flammability and excellent electrical 
insulation properties. This has led to their wide- 
spread use as industrial fluids, flame retardants 
and d&tents, and hydraulic fluids for capacitors 
and transformers. Careless disposal practices, e.g. 
leakage from disused equipment and disposal into 
sewers, rivers and coastal waters, have led to these 
compounds becoming one of the most abundant 
industrial pollutants in the ecosystem. These fat- 
soluble PCBs accumulate in biological systems by 
ingestion of PCB-contaminated lipid components 
of food chains, and PCBs are routinely detected in 
the fatty tissues of animals, including humans, at 
the apex of these food chains [l-3]. 
Commercial mixtures of PCBs (e.g. Aroclor 
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1254; see section 2) and individual isomers and con- 
geners have the ability to induce several forms of 
hepatic microsomal cytochrome P-450 (e.g. cyto- 
chromes P-450a to P-450e) as well as other enzyme 
systems involved in hepatic drug metabolism, in a 
fashion similar to that which occurs after treatment 
of rodents with phenobarbital (e.g. ‘phenobarbital- 
type’ induction), polycyclic aromatic hydrocarbons 
(e.g. ‘3-methylcholanthrene-type’ induction) or 
with a combination of both (e.g. ‘mixed type’ in- 
duction) [2]. 
It is not known whether PCB mixtures have the 
ability to induce cytochrome P-452, which is 
specifically induced in hepatic microsomes by 
hypolipidemic drugs such as clofibrate and by 
phthalate ester plasticisers [4]. Increased W- 
oxidation of the model substrate lauric acid (12 : 0) 
to 12-hydroxylauric acid by hepatic microsomes in 
response to treating rats with clofibrate has been 
attributed to the induction of cytochrome 
P-452-linked enzyme activities [4]. In contrast, 
treating rats with phenobarbital increases the (J - 1 
oxidation of lauric acid to 11 -hydroxylauric acid by 
hepatic microsomes, but does not increase the LJ- 
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oxidation of this substrate [5]. Since Aroclor 1254 
is known to be very versatile in inducing several 
forms of cytochrome P-450 in rat hepatic micro- 
somes, it was of interest to investigate whether it 
was also effective in inducing cytochrome 
P-452-linked enzyme activities. For comparison 
between species, the effects of Aroclor 1254 on 
pigeon hepatic microsomes were also measured. 
Two principal methods are available to measure 
the w- and w - 1 hydroxylation of radiolabeled 
lauric acid in vitro: (i) analysis of the resulting mix- 
ture by thin-layer chromatography and measure- 
ment of the radioactive products by liquid scintilla- 
tion [6]. Although rapid and simple, this method 
does not separate ll- and 12-hydroxylauric acids 
effectively; (ii) an advanced HPLC technique to 
separate 1 l- and IZhydroxylauric acids using a 
non-isocratic gradient and radiochemical detection 
[7]. We report here a new method of separating ll- 
and 12-hydroxyacids by high resolution capillary 
gas chromatography coupled with flame ionization 
detection that provides the accuracy and sensitivity 
required to measure the formation of these hydrox- 
yacids without using radiolabeled lauric acid as 
substrate. These products were then unambiguous- 
ly identified by high resolution capillary gas 
chromatography-mass spectrometry by com- 
parison with authentic standards. 
2. MATERIALS AND METHODS 
2.1. Aroclor 1254 
This was a gift from Dr J.P.G. Wilkens, MAFF Harpenden 
Laboratory, Herts, England. It is a mixture of chlorinated bi- 
phenyls, and contains approx. 70 different isomers and con- 
geners with molecular masses ranging from 188 to 430 Da. The 
average molecular mass for the mixture is 326 Da. 
2.2. Treatment with Aroclor 1254 
Adult female rats were given a single intraperitoneal injection 
of 600pmol/kg bodyweight of Aroclor 1254 in corn oil, and 
pigeons given a single intraperitoneal injection of 1500 pmol/kg 
of Aroclor 1254 in corn oil. Five days later the animals were 
killed and hepatic microsomes prepared from control and PCB- 
treated animals. 
2.3. Incubation conditions and extraction of hydroxylauric 
acids 
Microsomes (1 mg protein/ml) were incubated for 5 min in 
50 mM Tris-HCl buffer, pH 7.4, 150 mM MgCls, 500 mM 
nicotinamide, 12 mM NADP+,’ 12 mM glucose 6-phosphate, 
glucose 6-phosphate dehydrogenase (60 units) and 1 PM lauric 
acid (final volume 3 ml). The reaction was stopped with 7.5 ml 
methanol, 100 mg of methyl arachidate (methyl 2O:O) as inter- 
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nal standard and chloroform (16 ml) were added and the mix- 
ture vortexed. The aqueous phase was removed, the chloroform 
extract dried over anhydrous sodium sulphate, and evaporated 
to 0.5 ml. 
2.4. Separation by capillary gas chromatography and 
quantitation 
The hydroxy-fatty acids were silylated with Trisil (Pierce 
reagent), separated on a Chrompak CP Sil 5CB column 
(50 m X 0.22 mm i.d.) using a Packard 436 capillary gas-liquid 
chromatograph, and identified by comparison with the relative 
retention times of authentic standards. Quantitation was based 
on an internal standard method with prior calibration using 
known amounts of hydroxylauric acids. Samples were injected 
in the split mode with a split ratio of 55 : 1 at a carrier gas flow 
rate of 0.84 ml/min. Hydrogen was supplied to the flame 
ionization detector at 30 ml/min, as was nitrogen, with an air 
flow of approx. 220 ml/min. The temperature was programmed 
at 200°C for 15 min. raised at 30”C/min to 270°C and main- 
tained at 270°C. The capillary gas chromatograph was interfac- 
ed with a Digital Micro PDP 1 l/23 computer and ‘Multichrom’ 
software (V.G. Laboratories, England) to quantify the hydroxy- 
fatty acids against he known weight of 20: 0 methyl ester as in- 
ternal standard. The detection limit was estimated to be 
0.1 pmol. 
2.5. Identification of hydroxylauric acids 
The silylated hydroxy-fatty acids were identified unam- 
biguously by high resolution capillary gas chromatography- 
mass spectrometry using a Jeol JMS-DX 300 double-focussing 
mass spectrometer and an experimental protocol as described 
above. Samples were ionized in the electron impact mode with 
an accelerating voltage of 70 eV. The formation of hydroxy- 
fatty acids was linear with microsomal protein and incubation 
time. 
3. RESULTS AND DISCUSSION 
Table 1 summarizes the effects of a single injec- 
tion of Aroclor 1254 on the ability of rat and 
pigeon hepatic microsomes to metabolize lauric 
acid to the corresponding 1 l- and IZhydroxylauric 
acids. 
With female rats, there was a 5.2-fold increase in 
the formation of 12-hydroxylauric acid. This 
hepatic w-oxidation of lauric acid is specifically 
enhanced in animals in which cytochrome P-452 
has been induced, and lauric acid is known to be an 
excellent substrate to assay the induction of this 
cytochrome [4]. Previous work [5] had shown that 
treatment with the hypolipidemic drug clofibrate 
resulted in a specific 28-fold induction of hepatic 
microsomal w-oxidation of lauric acid in CD-l 
mice and marmoset monkeys, whereas phenobar- 
bital treatment increased 1 1-hydroxylation of 
lauric acid 2-fold but depressed 12-hydroxylation 
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Table 1 
Effect of polychlorinated biphenyl (PCB)-mediated induction 
of hepatic cytochrome P-450 on w- and w - 1 hydroxylation of 
lauric acid five days after treatment with Aroclor 1254 





12-Hydroxy 1 1-Hydroxy 
lauric acid Iauric acid 
formed formed 
0.36 + 0.12 0.41 + 0.17 
1.85 f l.O** 0.90 * 0.37* 
Pigeon None 0.12 * 0.06 0.15 f 0.04 
Aroclor 
(1500 ymol/kg) 0.10 + 0.01 0.30 + 0.07** 
* p<o.o5; ** ~~0.01; significant differences between control 
(n = 4) and treated (n = 5) rats, and between control (n = 4) and 
treated (n = 5) pigeons 
of lauric acid to 75% of control values. Hence our 
observation of a 2-fold increase in rat hepatic 
microsomal 1 1-hydroxylation of lauric acid is like- 
ly to be due to the known effects of Aroclor 1254 in 
inducing forms of cytochrome P-450 that catalyse 
the w - 1 hydroxylation of lauric acid. Unlike rats, 
pigeons did not respond to treatment with Aroclor 
1254 by specifically increasing the hepatic w- 
oxidation of lauric acid. The 2-fold increase 
observed with pigeons in the formation of 
1 1-hydroxylauric acid in response to Aroclor 1254 
treatment is similar to that observed with pheno- 
barbital-treated rats [4], and is therefore likely to 
be due to the induction of several forms of cyto- 
chrome P-450 that have the ability to hydroxylate 
lauric acid at the w - 1 position [2]. 
In conclusion, the r&u&s presented provide 
evidence for the induction of hepatic cytochrome 
P-452 in rats treated with Aroclor 1254. This sug- 
gests that Aroclor mixtures and individual isomers 
and congeners may produce a unique pattern of in- 
duction of different forms of hepatic cytochrome 
P-450 that is observed after treating rodents with 
phenobarbital, 3_methylcholanthrene, and a com- 
bination of both of these, as well as after treatment 
with hypolipidemic drugs and certain plasticisers. 
The results however also emphasize differences be- 
tween species in their response to treatment with 
PCB mixtures. 
The induction of cytochrome P-452 may have 
important biochemical consequences. For exam- 
ple, there is evidence that arachidonate is 
metabolized by purified cytochrome P-452 at the w 
and w i 1 positions [4]. In addition, immuno- 
chemical evidence for the induction of a number of 
different forms of cytochrome P-450 in animals in 
response to environmental levels of PCB pollution 
[8] raises the question of whether high levels of 
contamination with PCBs in humans could alter 
their response to treatment with hypolipidemic 
drugs. 
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